Clarification of FDA and the joint commission reporting requirements for US tissue recipient adverse reactions

Cell and Tissue Banking

Volumn 9, Issue 1, 2008, Pages 67-68

  Khoie, Tina ^a   Zinderman, Craig E ^a   Solomon, Ruth ^a   Wise, Robert P ^a   Lee, Karen C ^a   Nether, Klaus ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b Joint Commission   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; BACTERIAL INFECTION; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; FOOD AND DRUG ADMINISTRATION; GOOD CLINICAL PRACTICE; GRAFT RECIPIENT; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION PROCESSING; LETTER; MANDATORY REPORTING; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY CONTROL; TISSUE TRANSPLANTATION; UNITED STATES;

BACTERIAL INFECTIONS; COMMUNICABLE DISEASE CONTROL; HUMANS; TISSUE TRANSPLANTATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 39549105598     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-007-9043-2     Document Type: Letter

References (1)

1. Eastlund T (2006) Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Bank 7:147-166